Source: International Congress 2015 – Lung function: new findings and approaches
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Anders Christiansen (Middelfart, Denmark), Anders Christiansen, Ingrid L. Titlestad, Jørgen Vestbo. LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients. Eur Respir J 2015; 46: Suppl. 59, 2265

Member's Comments

No comment yet.

Related content which might interest you: Lung clearance index is increased in patients with COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016 LATE-BREAKING ABSTRACT: CAT for evaluation of recovery after severe exacerbation of COPD Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 LATE-BREAKING ABSTRACT: Within-breath changes of respiratory impedance in COPD and healthy adults Source: Annual Congress 2013 –Respiratory physiology in health and disease Year: 2013 Scintigraphic parameters in COPD patients Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 Comparison of protective effect of bronchodilators in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Prevalence of small airway dysfunction among GOLD stages in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Impulse-oscillometry (IOS) differences in asthma and COPD patients, and healthy-subjects Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 LATE-BREAKING ABSTRACT: Network-based meta-analysis of lung, sputum and blood transcriptomics in COPD Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Association between sputum cytology and lung function in patients with asthma and COPD Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 Body-plethysmographic measurements of bronchodilator response in stable COPD Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016